成人及儿童因肾功能恢复而脱离连续性肾脏替代治疗:文献综述与德尔菲共识
该文献综述与改良德尔菲共识检索了EMBASE、CINAHL、PubMed和CENTRAL中关于儿童及成人急性肾损伤患者脱离CRRT的文献,最终纳入18项研究(成人10项,n=3,357;儿童8项,n=939)。成人中2小时肌酐清除率>23 mL/min是成功脱离CRRT的强预测指标,尿量>60 mL/hr或>400 mL/day与成功脱离相关;儿童中脱离前6小时内尿量>0.5 mL/kg/hr似乎是可靠预测指标。由于研究数量有限、设计差异大、人群异质性显著、缺乏前瞻性及外部验证以及CRRT脱离缺乏标准化定义,无法进行汇总分析。当前推荐强调个体化脱离CRRT的方法。
要点
- 成人2小时肌酐清除率>23 mL/min是成功脱离CRRT的强预测指标(基于成人研究)。
- 成人尿量>60 mL/hr或>400 mL/day与成功脱离CRRT相关。
- 儿童脱离前6小时内尿量>0.5 mL/kg/hr似乎是可靠预测指标。
- 脱离CRRT前未使用利尿剂时的尿量是成功脱离最常报告的预测指标。
- 当前推荐强调个体化脱离CRRT,需额外前瞻性研究确定尿量阈值并验证其他临床和生化参数或风险分类模型。
适用人群与场景
- 成人及儿童急性肾损伤患者,正在接受连续性肾脏替代治疗(CRRT)。
诊断标准与关键阈值
- 成人:2小时肌酐清除率>23 mL/min(强预测成功脱离CRRT的指标)。
- 成人:尿量>60 mL/hr或>400 mL/day(与成功脱离CRRT相关)。
- 儿童:脱离前6小时内尿量>0.5 mL/kg/hr(似乎是可靠预测指标)。
研究设计与关键结果
- 文献综述纳入18项研究:成人CRRT脱离研究10项(n=3,357例),儿童CRRT脱离研究8项(n=939例)。
- 成人中2小时肌酐清除率>23 mL/min是成功脱离CRRT的强预测指标,尿量>60 mL/hr或>400 mL/day与成功脱离相关。
- 儿童中脱离前6小时内尿量>0.5 mL/kg/hr似乎是可靠预测指标。
- 由于研究数量有限、研究设计差异、患者人群显著异质性、缺乏前瞻性及外部验证以及CRRT脱离缺乏标准化定义,无法进行汇总分析。
证据类型、等级与局限
- 证据类型:文献综述与改良德尔菲共识(两轮改良德尔菲法)。
- 共识方法:超过75%的受访者在5点Likert量表上评分至少为3分的陈述被归类为临床相关实践要点;需要更多数据的陈述被标记为未来研究建议。
- 局限:研究数量有限、研究设计差异、患者人群显著异质性、缺乏前瞻性及外部验证、CRRT脱离缺乏标准化定义。
对床旁实践的改变
- 作者强调当前推荐需要个体化的CRRT脱离方法。
- 作者建议额外的前瞻性研究以加强这些推荐,重点在于确定尿量阈值并验证额外的临床和生化参数或风险分类模型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is no current consensus on the appropriate timing for discontinuing continuous renal replacement therapy (CRRT). We aimed to review the current clinical evidence associated with the successful liberation from CRRT in patients with acute kidney injury and present a literature review with clinical practice points using a modified Delphi process.
METHODS: EMBASE, CINAHL, PubMed, and CENTRAL libraries were searched for literature related to CRRT liberation in pediatric and adult AKI patients. A two-round modified Delphi process was conducted to establish clinical and research practice points for successful liberation from CRRT in adults and children. Statements with over 75% of respondents rating them at least a 3 on a 5-point Likert scale were classified as clinically relevant practice points. Statements requiring more data were labeled as future research recommendations.
RESULTS: Out of 1,380 articles procured, 18 studies met the eligibility criteria: ten studies on adult CRRT liberation (n = 3,357 patients) and eight on pediatric CRRT liberation (n = 939 patients). Demographic, clinical, and laboratory information were abstracted from the medical records. Four pediatric and five adult studies mentioned urine output (UOP). In adults, a 2-hour creatinine clearance above 23 mL/min was found to be a strong predictor of successful CRRT liberation, with UOP thresholds of > 60 mL/hr or > 400 mL/day correlating with successful outcomes. In pediatric patients, UOP > 0.5 mL/kg/hr within 6 h before liberation appeared to be a reliable predictor. A pooled analysis was unable to be conducted due to the limited number of studies, variations in study design, significant heterogeneity of patient populations, absence of prospective and external validation, and the lack of a standardized definition for CRRT liberation.
CONCLUSIONS: UOP without the use of diuretics prior to liberation from CRRT was the most commonly reported predictor for successful CRRT liberation. In addition to urine output, urinary creatinine excretion, creatinine clearance, and fluid balance may be considered as potential predictive parameters when liberating from CRRT. Current recommendations emphasize the need for an individualized approach to CRRT liberation. Additional prospective studies are needed to strengthen these recommendations, focusing on the determination of UOP thresholds and validating additional clinical and biochemical parameters or risk-classification models.
参考来源
- Raina R, Kashani K, Sethi SK, et al. Liberation from continuous renal replacement therapy due to renal recovery in adults and children: a literature review and Delphi consensus on clinical practice. Crit Care. 2025. PMID: 40629374. doi:10.1186/s13054-025-05517-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。